821 / 1481
Target Volume(s) in Prostate Cancer
•
WHY
do we want to treat?
PC Stage IIIA
EORTC 22863 Trial
Bolla et al Lancet Oncol 2010
PC T1-2, PSA ≤10, Gl ≤6
RTOG 0415 Trial
Lee et al JCO 2016
CMT
HYPO#
|
|
821 / 1481
Target Volume(s) in Prostate Cancer
•
WHY
do we want to treat?
PC Stage IIIA
EORTC 22863 Trial
Bolla et al Lancet Oncol 2010
PC T1-2, PSA ≤10, Gl ≤6
RTOG 0415 Trial
Lee et al JCO 2016
CMT
HYPO#